Patient Peak Skin Dose and Dose Area Product from Interventional Cardiology Procedures

Antar E. Aly, Ibrahim M. Duhaini, Samia M. Manaa, Sayed M. Tarique, Shehim E. Kuniyil, Huda M. Al Naemi

Hamad Medical Corporation, Doha, Qatar.

DOI: 10.4236/ijmpcero.2015.41002                

Abstract

Information about the peak skin dose and Dose Area product (DAP) from percutaneous transluminal coronary angioplasty (PTCA) and coronary angiography (CA) was collected from three catheter application rooms. The range of maximum photon energy was 50 - 125 kVp and the fluoroscopy time was 0.6 - 52 seconds. Values of up to 143 Gy·cm² for DAP and 0.752 mGy for cumulative dose (CD) were found in CA procedures. Otherwise the DAP and CD for PTCA were found to be 143 Gy·cm² and 2.287 mGy respectively in 3rd Quartile. The relation between the fluoroscopy time and the DAP is also considered. Objectives: The objective of this study is to obtain information about patient peak skin doses (PSD), dose area product (DAP), Fluoroscopy Time (FT) and Cumulative Dose (CD) from PTCA and CA which is the most predominant with respect to high skin doses in addition to other procedures. The aim of this study is also to assess the radiation dose received by patients undergoing interventional radiology procedures, by identifying the procedures that deliver the highest doses. This study is also helpful to establish the reference dose level for adult patients undergoing interventional procedure, and to provide recommendations on how to reduce dose on selected procedures that have been identified to deliver patient dose values near the ICRP (International Commission on Radiological Protection) threshold values.

Keywords

Interventional Radiology, Patient Dose, Fluoroscopy Time, Peak Skin Dose

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Wagner, L.K., Eifel, P.J. and Geise, R.A. (1994) Potential Biological Effects Following High X-Ray Dose Interventional Procedures. Journal of Vascular and Interventional Radiology, 5, 71-84. http://dx.doi.org/10.1016/S1051-0443(94)71456-1
[2]	Koenig, T.R., Wolff, D., Mettler, F.A. and Wagner, L.K. (2001) Skin Injuries from Fluoroscopically Guided Procedures: Part 1, Characteristics of Radiation Injury. American Journal of Roentgenology, 177, 3-11. http://dx.doi.org/10.2214/ajr.177.1.1770003
[3]	Shope, T.B. (1996) Radiation-Induced Skin Injuries from Fluoroscopy. RadioGraphics, 16, 1195-1199. http://dx.doi.org/10.1148/radiographics.16.5.8888398
[4]	Balter, S. (2001) Interventional Fluoroscopy: Physics, Technology, Safety. Wiley-Liss, New York.
[5]	Faulkner, K., Broadhead, D.A. and Harrison, R.M. (1999) Patient Dosimetry Measurement Methods. Applied Radiation and Isotopes, 50, 113-123. http://dx.doi.org/10.1016/S0969-8043(98)00031-1
[6]	Fernandez, J.M., Simon, R., Prieto, C., Martinez, D. and Vano, E. (2006) Medical Physics Service. San Carlos University Hospital Version 12, April 2006.
[7]	International Electrotechnical Commission (2000) IEC 2000: Particular Requirements for the Safety of X-Ray Equipments for Interventional Procedure. IEC 60601-60602-60603, Geneva.
[8]	Stecker, M.S., Balter, S. and Towbin, R.B. (2009) Guideline for Patient Radiation Dose Management. Journal of Vascular and Interventional Radiology, 20, 263-273.
[9]	Hansson, B. and Karambatsakidou, A. (2000) Relationships between Entrance Skin Dose, Effective Dose and Dose Area Product for Patients in Diagnostic and Interventional Cardiac Procedures. Radiation Protection Dosimetry, 90, 141-144. http://dx.doi.org/10.1093/oxfordjournals.rpd.a033104
[10]	Tsapaki, V., Nada, A., Adnan, B., Abdelkader, B., et al. (2009) Radiation Exposure to Patients during Interventional Procedures in 20 Countries: Initial IAEA Project Results. American Journal of Roentgenology, 193, 559-569. http://dx.doi.org/10.2214/AJR.08.2115